Abstract
INTRODUCTION
Gastric neuroendocrine neoplasms (g-NENs) are a highly heterogeneous and poorly understood group of relatively rare tumors that are derived primarily from enterochromaffin-like cells (ECL-cells) localized in the gastric mucosa [1] . Due to an increased understanding of g-NENs and improved diagnostic techniques, the incidence of g-NENs, which account for 6% of all neuroendocrine neoplasms, is increasing every year [2] . However, due to significant differences in the clinical pathology and biological characteristics, our knowledge regarding g-NENs is still very limited [3, 4] . The World Health Organization (WHO, 2010) classifies g-NENs into the following subclasses: neuroendocrine tumors (g-NETs), neuroendocrine carcinoma (g-NEC), and mixed adenoneuroendocrine carcinoma (g-MANEC) [5] . In addition to an early diagnosis, an important and effective component of proper management is the identification of the prognostic factors in patients with g-NENs. According to the American Joint Committee on Cancer/Union for International Cancer Control (AJCC/ UICC), the TNM staging system, which accounts for invasion depth, lymph node status, and metastases, is one of the most important prognostic factors in patients with g-NENs [6, 7] . However, the prognostic factors of these tumors are complex and multifaceted and have not been clearly defined thus far [8, 9] . In the past decade, increasing evidence has suggested that both tumor-associated neutrophils (TANs) and tumor-associated lymphocytes (TALs) are significantly associated with patient prognosis. Elevated TANs and reduced TALs correlate with advanced stage and poor prognosis in a variety of human tumors, including cervical cancer [10] , hepatocellular carcinoma [11] , and pancreatic cancer [12] . However, few studies have focused on the relationship between the tumorassociated neutrophil-to-lymphocyte ratio (TA-NLR) and the prognosis of patients with neuroendocrine neoplasms, particularly g-NENs.
This study investigated the utility of the TA-NLR as a prognostic indicator and evaluated its clinical value for the diagnosis and postoperative surveillance of patients undergoing radical surgery for g-NENs.
MATERIALS AND METHODS

General conditions
Overall, 173 patients who were diagnosed with g-NENs at Fujian Medical University Union Hospital between March 2006 and March 2015 were identified from a prospective database. The exclusion criteria for this study were as follows: metastatic disease confirmed preoperatively or during surgery (n = 11), perioperative death (n = 1), and incomplete/inaccurate medical records (n = 19). In all, 142 patients who underwent radical surgery were included in this study. The pathological data of these patients were reconfirmed by two pathologists according to the North American Neuroendocrine Tumor Society (NANETS) guidelines (2010) [13] . In total, 27 (19.0%) patients were diagnosed with g-NETs, 45 (31.7%) with g-NEC, and 70 (49.3%) with g-MANEC. The ethics committee of Fujian Union Hospital approved this retrospective study. Written consent was obtained from the patients, and their information was stored in the hospital database and used for research.
Immunohistochemistry analysis
Immunohistochemical staining for CD8 or CD15 was performed using formalin-fixed, paraffin-embedded tumor tissue sections (4-μm-thick) from 142 g-NENs ( Figure 1A) . Briefly, the slides were baked at 65 ℃ for 2 h, deparaffinized with xylene, and rehydrated in graded alcohol. The slides were subjected to antigen retrieval via the high-pressure method in antigen retrieval solution. Endogenous peroxidase was inactivated using 3% H2O2 in methanol. Non-specific binding was blocked via incubation in 1% bovine serum albumin (BSA; Sigma-Aldrich; St. Louis, MO, United States) in phosphate buffered saline (PBS). Subsequently, the slides were incubated overnight at 4 ℃ with a primary monoclonal mouse antibody against CD8 or CD15 (1:100 dilution; Zhongshan Golden Bridge Biotech, Beijing, China). Normal goat serum was used as a negative control. After being washed with PBS, tissue sections were incubated with the secondary antibody (Zhongshan Golden Bridge Biotech, Beijing, China) for 20 min at room temperature and then stained with diaminobenzidine (DAB). Finally, the slides were counterstained in hematoxylin, dehydrated, and mounted with a coverslip.
Two pathologists who were blinded to the clinical data reviewed the immunoreactivity under a light microscope. Inflammatory cells that had infiltrated the tumor nest and tumor stroma were analyzed, and inflammatory cells that were confined to lymph vascular spaces or within the vicinity of tumor necrosis or secretions were excluded from the analysis. Cases with tumor-infiltrating inflammatory cells present in 10 non-overlapping high-power fields (× 40) were examined in representative areas on two slides of a given tumor (i.e., a total of 20 fields per neoplasm). The number of tumor-related inflammatory cells was assessed in a semiquantitative manner using the mean value of high-power fields based on a × 40 objective (magnification × 400) [14, 15] . The TA-NLR was calculated as the average number of neutrophils (CD15-positive cells) divided by the average number of T lymphocytes (CD8-positive cells). A receiver operating characteristic (ROC) curve analysis was performed in relation to the occurrence of recurrence and death from any cause. For all 142 patients, a TA-NLR of 0.21 had the highest sensitivity and specificity for both outcomes. Therefore, patients were categorized into the following two groups: low TA-NLR group (≤ 0.21, 71 patients) and high TA-NLR group (> 0.21, 71 patients).
Postoperative follow-up
The patients were monitored after surgery via telephone interviews, outpatient visits, and letters. Our department follows a standardized surveillance protocol and follows patients at three-month intervals for the first two years, six-month intervals for years two to five, and at least once per year five years after surgery. The postoperative follow-up data included clinical symptoms and signs, laboratory tests, imaging examinations, and endoscopy and biopsy results. In this study, the median follow-up time was 40 mo (range, 2-106 mo). The overall survival (OS) time was calculated as the number of months from the date of surgery to the date of last contact, date of death from any cause, or the date the end point was realized. The recurrence-free survival (RFS) time was calculated as the number of months from the date of surgery to the date of identification of disease recurrence (either radiological or histological), the date of death or last contact, or the date the end point was realized.
Statistical analysis
All enumeration and measurement data were analyzed using SPSS 17 Figure 1 Relationship between the tumor-associated neutrophil-to-lymphocyte ratio and tumor recurrence. A: Representative immunohistochemical staining for CD15 (left) and CD8 (right); B: Significant differences in the TA-NLR were observed between the recurrence group (0.46% ± 0.05%, mean ± SE) and the nonrecurrence group (0.24% ± 0.03%, P < 0.001). TA-NLR: Tumor-associated neutrophil-to-lymphocyte ratio. Table 1 ). In addition, no significant differences were observed in the clinical symptoms, medical history, family history, active and past smoking histories, or history of heavy alcohol use between the two groups (P > 0.05 for all; Table 2 ).
Elevated TA-NLR is associated with a poor prognosis
As shown in Figure 2 , the RFS and OS were analyzed according to age, gender, tumor site and size, lymphovascular invasion, ASA status, postoperative complications, surgical approach, invasion depth, LNR, and Ki-67 index. The hazard ratios and 95% confidence interval (CI) for the RFS and OS were compared between the subgroups. The long-term survival time, including RFS and OS, was shorter in multivariate survival analysis was performed using a Cox proportional hazards model, and the significant variables from the univariate analysis were included in the model. R software (version 3.2.0) was utilized to develop the nomograms and the forest plot. P < 0.05 was considered significant.
RESULTS
TA-NLR is not associated with clinicopathological factors
The univariate analysis revealed that the TA-NLR was associated with the invasion depth, LNR (lymph node ratio), and postoperative complications (P < 0.05 for all; Table 1 ). However, the multivariate analysis revealed no significant differences in the Cao LL et al . Tumor-associated NLR in g-NENs the high TA-NLR group compared with the low TA-NLR group.
TA-NLR is an independent prognostic factor for RFS and OS
The univariate analysis found that larger tumor size, occurrence of postoperative complications, greater invasion depth, higher LNR, higher Ki-67 index, and higher TA-NLR were prognostic indicators of poorer RFS (P < 0.05 for all; Table 3 ). The tumor size, invasion depth, LNR, Ki-67 index, and TA-NLR were identified as prognostic indicators of OS (P < 0.05 for all; Table 4 ). According to the multivariate analysis, the Ki-67 index, LNR, and TA-NLR were independent prognostic factors of RFS and OS (P < 0.05 for all; Tables 3 and 4) .
TA-NLR is significantly correlated with recurrence site
The TA-NLR was significantly higher in the recurrence group than in the non-recurrence group (P < 0.05 for both; Figure 1B ). Details regarding the recurrence site following surgery are listed in rate was significantly higher in the high TA-NLR group compared with the low TA-NLR group (P < 0.001).
Additionally, an elevated TA-NLR was significantly associated with both liver metastasis and lymph node metastasis (P < 0.05 for both).
TA-NLR, combined with the Ki-67 index and LNR, is a superior prognostic prediction system
Prognostic nomograms were established using R software ( Figure 3 ). The C-index of the nomograms for RFS (OS), which included the TA-NLR, LNR, and Ki-67 index, was 0.788 (0.759). However, the C-index of the TNM staging system for RFS (OS) was 0.673 (0.662) (Figure 4 ). Thus, both the TNM staging system and the nomograms had superior abilities to predict clinical outcomes for patients with g-NENs.
DISCUSSION
Neuroendocrine neoplasms, particularly g-NENs in the digestive system, are a unique subgroup of tumors with great clinical heterogeneity and varied biology. In recent years, with the growing popularity of upper gastrointestinal endoscopy and increasing improvements in diagnostic techniques, the reported incidence of g-NENs has increased each year, and currently, the incidence is approximately 0.3 per 100 thousand [16, 17] . According to previous studies, a patient's prognosis is significantly associated with the clinical and pathological parameters as well as the biological characteristics of g-NENs [18] [19] [20] . However, the independent prognostic factors for g-NEN patients are still controversial. To our knowledge, studies have reported individual prediction models for the prognosis of g-NENs. We evaluated the prognostic value of TA-NLR in patients with g-NENs and further established a tumor prognosis prediction model to provide a basis for individual clinical therapy.
In most cases, the clinical symptoms of g-NENs are not typical because they depend on the location and invasiveness of the primary tumor or metastases. The symptoms mainly include abdominal pain, abdominal distension, difficulty swallowing, nausea, and vomiting. In this study, abdominal pain was the most common symptom, followed by weight loss, difficulty swallowing, and gastrointestinal bleeding; this finding is consistent with previous reports [21] . In addition, approximately 6% of the patients without any clinical symptoms were diagnosed via physical examinations. Among asymptomatic patients, approximately 40% were diagnosed with g-NEC or g-MANEC, although most of them were diagnosed with g-NETs. Therefore, postoperative follow-up is still essential for patients who have no clinical symptoms.
In recent years, substantial evidence has revealed that pathological stage is closely related to the prognosis of patients with g-NENs. Deep tumor invasion, lymph node metastasis, and distant metastasis were associated with decreased longterm survival [8, 9, 22] . The Ki-67 index, as a marker of cell proliferation, is widely used to evaluate the malignant potential of neuroendocrine tumors. The European Neuroendocrine Tumor Society (ENETS) and the WHO adopted a three-tier classification system based on the Ki-67 index for gastrointestinal pancreatic neuroendocrine tumors (G1: ≤ 2%; G2: 3%-20%; G3: > 20%). The Ki-67 index combined with a pathological staging system improves the diagnosis and prognosis prediction of patients with neuroendocrine tumors, and it is thus widely used in clinical practice. In this study, the rate of lymph node metastasis and the Ki-67 index were independent risk factors for OS and RFS in patients with g-NENs. In addition, increasing evidence has confirmed that the tumor-associated inflammatory response is closely related to the prognosis of patients with malignant tumors [12, 23, 24] . However, the relationship between the tumor-associated inflammatory response and g-NENs is unclear. Our study is the first to confirm that the TA-NLR is significantly associated with the prognosis of patients with g-NENs. We observed, through a univariate analysis, that the RFS and OS rates in patients with a TA-NLR > 0.21 were significantly lower than the rates in patients with a TA-NLR < 0.21. The multivariate analysis further revealed that the TA-NLR was an independent risk factor for patients with g-NENs.
Postoperative local recurrence and distant metastasis are the leading causes of death for patients with malignant tumors. Liver metastasis, peritoneal metastasis, and lymph node metastasis were the Cao LL et al . Tumor-associated NLR in g-NENs main types of tumor recurrence. The proportions of patients with these types of recurrence were 72%, 28%, and 25%, respectively. The spleen, kidney, and brain were relatively rare sites of recurrence. Our results are similar to those of previous reports [9] . In the present study, the TA-NLR was closely related to tumor B recurrence, and a high incidence of liver metastasis and lymph node metastasis was observed in patients with a high TA-NLR. Thus, during the postoperative follow-up period, clinicians should utilize the prognostic value of the TA-NLR, as well as clinical characteristics, to discover potential hepatic or lymph node metastases at an earlier time point. Nomograms, as a new type of statistical prediction model, are currently widely used in clinical practice for the majority of cancer types [25, 26] . Prognostic nomograms enable the use of a combination of multiple relevant clinical predictors and can be utilized to predict RFS and OS for individual patients. For many cancers, nomograms compare favorably to the traditional TNM staging system and have been proposed as an important tool in clinical practice [13, 27] . In this study, we established prognostic nomograms for g-NENs by combining the TA-NLR, Ki-67 index, and LNR. This combination had a high predictive ability, as did the traditional TNM staging system. Therefore, the combination of the TA-NLR, Ki-67 index, and LNR, as a novel prognostic system, may provide simple, more accurate prognostic predictions.
This study had some limitations. The study was uncontrolled and performed in a single institution. The results should be confirmed by subsequent prospective studies. Some heterogeneity was also present in this study, as it included multiple histological types (including NET, NEC, and MANEC), which do not represent a specific progression of a unique Cao LL et al . Tumor-associated NLR in g-NENs pathologic process. Due to the low incidence of g-NENs and the limited number of samples in the study, a statistical analysis could not be conducted for any one histological type. We will focus on each of the three histological types in the future, after more cases have been accumulated. However, to our knowledge, our study enrolled more patients with g-NENs than similar reports in the literature, and for the first time, we demonstrated that the TA-NLR was able to predict long-term survival relatively accurately in patients. Our study could be the basis for a subsequent prospective clinical study. As a simple and inexpensive inflammatory biomarker, the TA-NLR is significantly correlated with tumor recurrence, especially with liver and lymph node metastasis. The TA-NLR is an independent predictor of RFS and OS, and its combination with the Ki-67 index and LNR could improve prognosis prediction in g-NEN patients undergoing radical surgery, as could the traditional TNM staging system.
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